Molecular bssis of mef-mediated antibiotic resistance in Streptococcus pneumoniae
Molecular bssis of mef-mediated antibiotic resistance in Streptococcus pneumoniae
批准号:
7900062
负责人:
DAVID S STEPHENS
金额:
$37.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-15 至 2012-07-31
关键词:
AbbreviationsAccountingAddressAdenineAfricaAllelesAntibiotic ResistanceAntibioticsAntibodiesAntimicrobial ResistanceAsiaAzithromycinBacteriaBase SequenceBe++ elementBerylliumBindingBinding SitesBiological AssayBoxingCanadaCell WallChimera organismClarithromycinClinicalColorCompetenceDNA RepairDataDirect RepeatsDiseaseDrug DesignElementsErythromycinEscherichia coliEuropeFluoroquinolonesFrameshift MutationFundingGenerationsGenesGeneticGenetic ScreeningGenetic StructuresGenomeGenus staphylococcusGram-Positive BacteriaGray unit of radiation doseHeadHealthHomologous GeneHumanIndiumInfectionKetolidesLeadLettersMacrolide-resistanceMacrolidesMeasuresMediatingMembraneMeningealMethyltransferaseMobile Genetic ElementsMolecularMutationOpen Reading FramesOperonPeptidyltransferasePneumococcal 7-Valent Conjugate VaccinePneumococcal InfectionsPneumococcal conjugate vaccinePneumoniaPopulationPredispositionPrevalencePrincipal InvestigatorPromoter RegionsProteinsProton-Motive ForcePumpRNARegulationRegulatory ElementRegulonReporter GenesReportingResearchResearch PersonnelResistanceRibosomal ProteinsRibosomal RNARoleSeriesSerotypingSiteSite-Directed MutagenesisSon of Sevenless ProteinsStaphylococcus epidermidis msrA proteinStreptococcus Group BStreptococcus pneumoniaeStreptococcus pyogenesStreptococcus salivariusStreptogramin BStructureSubstrate SpecificitySystemTherapeutic InterventionTranscriptional RegulationTranslationsTrimethoprimUnited StatesVirulence FactorsWorkbasebeta-Lactam Resistancebeta-Lactamsbiological adaptation to stresscapsuleefflux pumpgenetic elementinsightlincosamidemeetingsmutantnovelpathogenprogramspromoterresistance mechanismresistant straintelithromycin
中文摘要
描述(由申请人提供):肺炎链球菌中出现mefE相关的大环内酯类耐药性的基础是遗传元件mega(大环内酯外流基因组装)。 Mega最初出现在肺炎球菌血清型(例如14、6B、9V、19F和6A)中,现在已出现在血清型(例如33F、19A)中,导致替换携带和疾病。 我们鉴定并表征了肺炎链球菌中的大遗传位点。 mefE 基因以单拷贝形式存在于肺炎链球菌基因组中 5.5 kb 或 5.4 kb 染色体插入片段的 5' 端。 至少已鉴定出四个巨噬细胞插入位点。 除了mefE之外,在mega中还发现了组织成两个聚合簇的其他四个开放阅读框(ORF)。 mefE 的紧下游是一个 ORF,命名为 mel,它与表皮葡萄球菌的红霉素抗性 ATP 结合盒 (ABC) 蛋白 MsrA 具有显着的同源性。 mega 的 3' 端包含三个聚合转录的 ORF(ORF5、ORF4、ORF3),与 47.5 kb 转座子 Tn5252 中的 ORF 同源。 在含有 mefE 的侵袭性肺炎链球菌分离株中,在流行病学和遗传上不相关的菌株的肺炎球菌基因组中至少有四个不同位点发现了 mega。 mefE和mel的基因产物都是大环内酯类抗药性所必需的,它们协同工作、协调调节,并且可由大环内酯类诱导。 目前已在肺炎链球菌的 Tn1207.1、Tn1207.3、Tn2009 中以及化脓性链球菌、B 族链球菌和其他革兰氏阳性菌中的相关元素中发现了巨量元素同系物。 在两个具体目标中,我们将进一步描述肺炎链球菌中 mef 介导的大环内酯类耐药的巨量元素和遗传基础。将检验两个假设:首先,mega 的 Mef 和 Mel 代表革兰氏阳性细菌中的一种新型外排泵,由两种不同的外排蛋白、ABC 膜结合转运蛋白和质子动力转运蛋白组成。其次,mega是与接合转座子相关的缺陷或“搭便车”遗传元件。 Tn5252 或其他接合转座子增强了 mega 的水平转移和外排活性。 此外,ORF 3-5通过能力诱导和诱导肺炎球菌SOS应激反应的药物(例如磺胺甲氧苄氨嘧啶、氟喹诺酮类药物)促进了mega的快速出现及其在肺炎链球菌中的持续传播。 在具体目标 1 中,将确定外排泵的分子基础、调节和底物特异性,并评估外排泵作为毒力因子的潜在作用。 在具体目标 2 中,将确定影响肺炎链球菌群体中巨量传播(水平转移)和流出功能的因素。这些研究应进一步深入了解这种新型遗传元件和外排泵传播的分子基础和机制,并更好地了解肺炎链球菌抗生素耐药性的出现。
英文摘要
DESCRIPTION (provided by applicant): The basis for the emergence of mefE-associated macrolide resistance in Streptococcus pneumoniae is a genetic element, mega (macrolide efflux genetic assembly). Mega initially emerged in pneumococcal serotypes (e.g., 14, 6B, 9V, 19F and 6A) and has now appeared in serotypes (e.g., 33F, 19A) causing replacement carriage and disease. We identified and characterized the mega genetic locus in S. pneumoniae. The mefE gene is found in single copy on the 5' end of a 5.5 kb or 5.4 kb chromosomal insert in the S. pneumoniae genome. At least four sites of insertion of mega have been identified. In addition to mefE, four other open reading frames (ORFs) organized into two convergent clusters are found in mega. Immediately downstream of mefE is an ORF, designated mel, that had significant homology to the erythromycin resistance ATP-binding cassette (ABC) protein, MsrA, of Staphylococcus epidermidis. The 3' end of mega contains three convergently transcribed ORFs (ORF5, ORF4, ORF3), homologous to ORFs in the 47.5 kb transposon Tn5252. In mefE-containing invasive S. pneumoniae isolates, mega is found in at least four distinct sites in the pneumococcal genome in epidemiologically and genetically unrelated strains. The gene products of mefE and mel are both required for macrolide resistance, work in concert, are coordinately regulated, and are inducible by macrolides. Mega element homologs have now been found in Tn1207.1, Tn1207.3, Tn2009 in S. pneumoniae and related elements in S. pyogenes, group B streptococci and in other Gram-positive bacteria. In two Specific Aims, we will further characterize the mega element and the genetic basis of mef-mediated macrolide resistance in S. pneumoniae. Two hypotheses will be examined: first, Mef and Mel of mega represent a novel efflux pump in Gram-positive bacteria composed of two distinct efflux proteins, an ABC membrane-bound transporter and a proton motive force transporter. Second, mega is a defective or "hitchhiker" genetic element related to conjugative transposons. The horizontal transfer and efflux activity of mega is enhanced by Tn5252 or other conjugative transposons. Also, the rapid emergence of mega and its continued spead in S. pneumoniae has been facilitated through ORFs 3-5 by competence induction and by agents, e.g., trimethoprim-sulfa, fluoroquinolones, that induce an SOS stress response in pneumococci. In Specific Aim 1, the molecular basis, regulation and substrate specificity of the efflux pump will be determined and the pump's potential role as a virulence factor assessed. In Specific Aim 2, the factors that impact the dissemination of mega (horizontal transfer) and efflux functions in the S. pneumoniae population will be determined. These studies should provide further insights into the molecular basis and mechanism(s) of dissemination of this novel genetic element and efflux pump and provide greater understanding of the emergence of antibiotic resistance in S. pneumoniae.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0116254
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Chancey ST, Bai X, Kumar N, Drabek EF, Daugherty SC, Colon T, Ott S, Sengamalay N, Sadzewicz L, Tallon LJ, Fraser CM, Tettelin H, Stephens DS]
通讯作者:
Stephens DS
DOI:
10.1371/journal.pone.0025124
发表时间:
2011
期刊:
PloS one
影响因子:
3.7
作者:
[Zähner D, Gandhi AR, Yi H, Stephens DS]
通讯作者:
Stephens DS
Pilus backbone protein PitB of Streptococcus pneumoniae contains stabilizing intramolecular isopeptide bonds.
肺炎链球菌的菌毛骨架蛋白 PitB 含有稳定的分子内异肽键。
DOI:
10.1016/j.bbrc.2011.05.038
发表时间:
2011
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Zahner,Dorothea, Gandhi,AshishR, Stuchlik,Olga, Reed,Matthew, Pohl,Jan, Stephens,DavidS]
通讯作者:
Stephens,DavidS
DOI:
10.2217/fmb.12.63
发表时间:
2012-08
期刊:
Future microbiology
影响因子:
3.1
作者:
[Chancey ST, Zähner D, Stephens DS]
通讯作者:
Stephens DS
DOI:
10.3389/fmicb.2015.00026
发表时间:
2015
期刊:
Frontiers in microbiology
影响因子:
5.2
作者:
[Chancey ST, Agrawal S, Schroeder MR, Farley MM, Tettelin H, Stephens DS]
通讯作者:
Stephens DS
共 6 条
DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE
-
批准号:9888324
-
项目类别:
-
资助金额:$16.41万
-
财政年份:2019
-
负责人:DAVID S STEPHENS
-
依托单位:
DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE
-
批准号:10027021
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2019
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8366095
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8366091
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8366093
-
项目类别:
-
资助金额:$272.54万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE
-
批准号:8366094
-
项目类别:
-
资助金额:$66.74万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8366092
-
项目类别:
-
资助金额:$189.12万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173821
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8173819
-
项目类别:
-
资助金额:$227.88万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8173818
-
项目类别:
-
资助金额:$124.79万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173817
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE
-
批准号:8173820
-
项目类别:
-
资助金额:$146.49万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (UL1)
-
批准号:7900241
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2009
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (UL1)
-
批准号:7900242
-
项目类别:
-
资助金额:$99.88万
-
财政年份:2009
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:7719800
-
项目类别:
-
资助金额:$64.37万
-
财政年份:2008
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:7719802
-
项目类别:
-
资助金额:$223.82万
-
财政年份:2008
-
负责人:DAVID S STEPHENS
-
依托单位:
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE
-
批准号:7719803
-
项目类别:
-
资助金额:$127.89万
-
财政年份:2008
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:7719801
-
项目类别:
-
资助金额:$127.89万
-
财政年份:2008
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (KL2)
-
批准号:8133799
-
项目类别:
-
资助金额:$59.19万
-
财政年份:2007
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal
-
批准号:8467208
-
项目类别:
-
资助金额:$24.32万
-
财政年份:2007
-
负责人:DAVID S STEPHENS
-
依托单位:
海外基金